Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tagawa

Showing results (261-270 of 419) with videos related to

Pageof 42
Sort By:
Prostate Cancer and Prostatic Diseases|February 22, 2021
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetateScott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
JCO Oncology Practice|January 18, 2022
Use of Biosimilar Medications in OncologyZeina Nahleh, Gary H Lyman, Richard L Schilsky, et al.
Gut|August 25, 2005
Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in miceA Ogawa, T Tagawa, H Nishimura, et al.
Blood|December 23, 2018
Arterial thromboembolic events preceding the diagnosis of cancer in older personsBabak B Navi, Anne S Reiner, Hooman Kamel, et al.
Cancer|July 2, 2003
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanomaScott T Tagawa, Peter Lee, Jolie Snively, et al.
Thrombosis Research|May 11, 2016
OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparinC I Piatek, S T Tagawa, D Wei-Tsai, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Antibody-Drug Conjugates in Bladder CancerPanagiotis J Vlachostergios, Christopher D Jakubowski, Muhammad J Niaz, et al.
Urologic Oncology|August 25, 2024
Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: Perspective from a low- and middle- income country in sub-Saharan AfricaMusliu Adetola Tolani, Ismail Hadi Zubairu, Kabir Balarabe, et al.
Brain & Development|January 1, 1982
Antiepileptic effects of clobazam in childrenH Shimizu, J Abe, Y Futagi, et al.
Translational Oncology|December 26, 2022
Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trialJuana Martinez, Kritika Subramanian, Sandra Huicochea Castellanos, et al.
Pageof 42

Showing results (261-270 of 419) with videos related to

Sort By:
Pageof 42
Prostate Cancer and Prostatic Diseases|February 22, 2021
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetateScott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
JCO Oncology Practice|January 18, 2022
Use of Biosimilar Medications in OncologyZeina Nahleh, Gary H Lyman, Richard L Schilsky, et al.
Gut|August 25, 2005
Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer's patch and the liver at an early stage after bile duct ligation in miceA Ogawa, T Tagawa, H Nishimura, et al.
Blood|December 23, 2018
Arterial thromboembolic events preceding the diagnosis of cancer in older personsBabak B Navi, Anne S Reiner, Hooman Kamel, et al.
Cancer|July 2, 2003
Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanomaScott T Tagawa, Peter Lee, Jolie Snively, et al.
Thrombosis Research|May 11, 2016
OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparinC I Piatek, S T Tagawa, D Wei-Tsai, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
Antibody-Drug Conjugates in Bladder CancerPanagiotis J Vlachostergios, Christopher D Jakubowski, Muhammad J Niaz, et al.
Urologic Oncology|August 25, 2024
Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: Perspective from a low- and middle- income country in sub-Saharan AfricaMusliu Adetola Tolani, Ismail Hadi Zubairu, Kabir Balarabe, et al.
Brain & Development|January 1, 1982
Antiepileptic effects of clobazam in childrenH Shimizu, J Abe, Y Futagi, et al.
Translational Oncology|December 26, 2022
Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trialJuana Martinez, Kritika Subramanian, Sandra Huicochea Castellanos, et al.
Pageof 42